Age-Dependent Prognostic Effects of Genetic Alterations in Glioblastoma

Clinical Cancer Research

Volumn 10, Issue 1 I, 2004, Pages 228-233

  Batchelor, Tracy T ^a   Betensky, Rebecca A ^b   Esposito, J Matthew ^a   Pham, Loc Duyen D ^a   Dorfman, Molly V ^a   Piscatelli, Nicole ^a   Jhung, Sarah ^a   Rhee, David ^a   Louis, David N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P16; PROTEIN P53;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARCINOGENESIS; CHROMOSOME 10Q; CHROMOSOME 19Q; CHROMOSOME 1P; COHORT ANALYSIS; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 19; COHORT STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE FREQUENCY; GLIOBLASTOMA; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1642453725     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0841-3     Document Type: Article

References (18)

1. Central Brain Tumor Registry of the United States. Statistical Report: Primary Brain Tumors in the United States, 1995-1999. Central Brain Tumor Registry of the United States, 2002.
2. The Medical Research Council Brain Tumour Working Party: Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial. J. Clin. Oncol., 19: 509-518, 2001.
3. Von Deimling, A., von Ammon, K., Schoenfeld, D., Wiestler, O. D., Seizinger, B. R., and Louis, D. N. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol., 3: 19-26, 1993.
4. Louis, D. N., and Cavenee, W. K. Molecular biology of central nervous system tumors. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, Ed. 6. Philadelphia: Lippincott-Raven, 2091-2100, 2001
5. Simmons, M. L., Lamborn, K. R., Takahashi, M., Chen, P., Israel, M. A., Berger, M. S., Godfrey, T., Nigro, J., Prados, M., Chang, S., Barker, F. G., and Aldape, K. Analysis of complex relationships between age, p53, EGFR, and survival in glioblastoma patients. Cancer Res., 61: 1122-1128, 2001.
6. Louis, D. N., von Deimling, A., and Seizinger, B. R. A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. Am. J. Pathol., 141: 777-782, 1992.
7. Cairncross, J. G., Ueki, K., Zlatescu, M. C., Lisle, D. K., Finkelstein, D. M., Hammond, R. R., Silver, J. S., Stark, P. C., Macdonald, D. R., Ino, Y., Ramsay, D. A., and Louis, D. N. Specific chromosomal losses predict chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J. Natl. Cancer Inst. (Bethesda), 90: 1473-1479, 1998.
8. Rubio, M. P., von Deimling, A., Yandell, D. W., Wiestler, O. D., Gusella, J. F., and Louis, D. N. Accumulation of wild-type p53 protein in human astrocytomas. Cancer Res., 53: 3465-3467, 1993.
9. Ueki, K., Ono, Y., Henson, J. W., von Deimling, A., and Loius, D. N. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res., 56: 150-153, 1996.
10. Ono, Y., Tamiya, T., Ichikawa, T., Kunishio, K., Matsumoto, K., Furuta, T., Ohmoto, T., Ueki, K., and Louis, D. N. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices. J. Neuropathol. Exp. Neurol., 55: 1026-1031, 1996.
11. Louis, D. N., Rubio, M-P., Correa, K., Gusella, J. F., and von Deimling, A. Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens. J. Neuropath. Exp. Neurol., 52: 507-515, 1993.
12. Ershler, W. B. Do old people get old tumors? In: M. C. Perry (ed.), American Society of Clinical Oncology Educational Book, pp. 87-90. Alexandria: American Society of Clinical Oncology, 2000.
13. Van Tol, K. M., de Vries, E. G. E., Dullaart, R. P. F., and Links, T. P. Differentiated thyroid carcinoma in the elderly. Crit. Rev. Oncol. Hematol., 38: 79-91, 2001.
14. Ito, Y., Takeda, T., Sakon, M., Tsujimoto, M., Higashiyama, S., Noda, K., Miyoshi, E., Monden, M., and Matsuura, N. Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma. Br. J. Cancer, 84: 1377-1393, 2001.
15. Garvin, A. M., Eppenberger, U., Müller, H., Eppenberger-Castori, S., and Scott, R. J. BRCA1 mutations found in archived early onset breast tumours. Eur. J. Cancer, 33: 683-686, 1997.
16. Bogdani, M., Teugels, E., De Grève, J., Bourgain, C., Neyns, B., and Pipeleers Marichal, M. Loss of nuclear BRCA1 localization in breast carcinoma is age dependent. Virchows Arch., 440: 274-279, 2002.
17. Kunwar, S., Mohapatra, G., Bollen, A., Lamborn, K. R., Prados, M., and Feuerstein, B. G. Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival. Cancer Res., 61: 7683-7688, 2001.
18. Barker, F. G., Simmons, M. L., Chang, S. M., Prados, M. D., Larson, D. A., Sneed, P. K., Wara, W. M., Berger, M. S., Chen, P., Israel, M. A., and Aldape, K. D. EGFR overexpression and radiation response in glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys., 51: 410-418, 2001.